Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution

Archive ouverte

Malve, Brice | Eschlimann, Marine | Galgey, Shaunagh | Fenaux, Honorine | Zoulim, Fabien | Goehringer, François | Rabaud, Christian | May, Thierry | Jeulin, Hélène | Schvoerer, Evelyne

Edité par CCSD ; Elsevier -

International audience. The Hepatitis B virus (HBV) envelope glycoproteins are essential for viral entry into the hepatocyte and are also targets for host immune response. The study of these proteins could allow us to highlight molecular hot points influencing HBV fitness, which would subsequently modify the clinical evolution of the disease, both under anti-viral therapy or without treatment. The present short communication underlines the importance of the high variability in HBV envelope proteins, in regard with the literature and in our hands, for HBV-infected patients either on anti-HBV treatment or not. We report mutations in antigenic areas of S protein, i.e. CD8+/CD4+ T-cell epitopes and B-cell epitopes in the major hydrophilic region (MHR), such as sI126N and sG145R possibly involved in the rare coexisting Hepatitis B surface Antigen (HBsAg)/anti-HBs serological pattern. We mostly report serial mutations in preS region including preS1 deletion (aa 1-6, 31-71, 38-73, 72-104) and preS2 deletion (aa132-141) in patients with various clinical evolutions. Some of these viral envelope mutations, due to immune selection pressure, may result in a worsening of the hepatic disease.

Consulter en ligne

Suggestions

Du même auteur

The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection

Archive ouverte | Eschlimann, Marine | CCSD

International audience

Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohort

Archive ouverte | Jeulin, Helene | CCSD

International audience

Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients

Archive ouverte | Yazdanpanah, Yazdan | CCSD

International audience

Chargement des enrichissements...